Trial Profile
Comparison of effects of a DPP-4 inhibitor and an alpha-glucosidase inhibitor on visceral fat and oxidative stress in type 2 diabetes mellitus
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Jun 2017
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Acarbose
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 02 Jun 2017 Planned End Date changed from 31 Mar 2016 to 30 Sep 2018.
- 02 Oct 2013 New trial record